MIRA Pharmaceuticals, Inc.
Regulated industryPhysical productsDevelopment stageTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $0.59
- 52-Week Range
- $0.34 – $1.69
- Market Cap
- $15.48M
- P/E (TTM)
- 36.83
- EPS (TTM)
- 0.01
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 2.26
- PEG Ratio
- —
- Return on Equity
- -135.71%
- Return on Assets
- -79.66%
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Profit Margin
- 0.00%
- Current Ratio
- 16.97
- Debt/Equity
- 0.03
- Total Debt
- $194.19K
- Free Cash Flow
- $327.72K
- Revenue Growth
- —
- Earnings Growth
- —
- Enterprise Value
- $18.06M
Market Snapshot
About
MIRA Pharmaceuticals is a pre-clinical biotech company developing cannabinoid-based therapies. The company focuses on novel drug candidates for neurological disorders and other medical conditions.